https://stock.noler.com/us/stock/rain-oncology-inc https://stock.noler.com/us/stock/rain-oncology-inc/accounts-payable https://stock.noler.com/us/stock/rain-oncology-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/rain-oncology-inc/accrued-bonuses-current https://stock.noler.com/us/stock/rain-oncology-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/rain-oncology-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/rain-oncology-inc/accumulated-depreciation https://stock.noler.com/us/stock/rain-oncology-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/rain-oncology-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/rain-oncology-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/rain-oncology-inc/aoci https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-accrued-interest-after-allowance-for-credit-loss https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-accrued-interest-writeoff https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/rain-oncology-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/rain-oncology-inc/basic-shares https://stock.noler.com/us/stock/rain-oncology-inc/capital-expenditures https://stock.noler.com/us/stock/rain-oncology-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/rain-oncology-inc/cash-and-equivalents https://stock.noler.com/us/stock/rain-oncology-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/rain-oncology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/rain-oncology-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/rain-oncology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rain-oncology-inc/common-stock-value https://stock.noler.com/us/stock/rain-oncology-inc/comprehensive-income https://stock.noler.com/us/stock/rain-oncology-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/rain-oncology-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/rain-oncology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/rain-oncology-inc/current-assets https://stock.noler.com/us/stock/rain-oncology-inc/current-liabilities https://stock.noler.com/us/stock/rain-oncology-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/rain-oncology-inc/deferred-offering-costs https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rain-oncology-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/rain-oncology-inc/deposits-assets-current https://stock.noler.com/us/stock/rain-oncology-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/rain-oncology-inc/depreciation https://stock.noler.com/us/stock/rain-oncology-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/rain-oncology-inc/diluted-shares https://stock.noler.com/us/stock/rain-oncology-inc/dilutive-shares https://stock.noler.com/us/stock/rain-oncology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/rain-oncology-inc/eps https://stock.noler.com/us/stock/rain-oncology-inc/eps-basic https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/rain-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/rain-oncology-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/rain-oncology-inc/financing-cash-flow https://stock.noler.com/us/stock/rain-oncology-inc/form-d-other https://stock.noler.com/us/stock/rain-oncology-inc/form-d-stocks https://stock.noler.com/us/stock/rain-oncology-inc/gain-loss-on-investments https://stock.noler.com/us/stock/rain-oncology-inc/general-and-administrative-expense https://stock.noler.com/us/stock/rain-oncology-inc/income-tax https://stock.noler.com/us/stock/rain-oncology-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/rain-oncology-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/rain-oncology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/rain-oncology-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/rain-oncology-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/rain-oncology-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/rain-oncology-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/rain-oncology-inc/insider-transactions-other https://stock.noler.com/us/stock/rain-oncology-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/rain-oncology-inc/insider-transactions-preferred https://stock.noler.com/us/stock/rain-oncology-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/rain-oncology-inc/interest-expense-on-debt https://stock.noler.com/us/stock/rain-oncology-inc/interest-expense-related-party https://stock.noler.com/us/stock/rain-oncology-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/rain-oncology-inc/investing-cash-flow https://stock.noler.com/us/stock/rain-oncology-inc/investment-income-interest https://stock.noler.com/us/stock/rain-oncology-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/rain-oncology-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/rain-oncology-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/rain-oncology-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/rain-oncology-inc/maturities-of-shortterm-investments https://stock.noler.com/us/stock/rain-oncology-inc/net-change-in-cash https://stock.noler.com/us/stock/rain-oncology-inc/net-income https://stock.noler.com/us/stock/rain-oncology-inc/number-of-operating-segments https://stock.noler.com/us/stock/rain-oncology-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/rain-oncology-inc/operating-cash-flow https://stock.noler.com/us/stock/rain-oncology-inc/operating-expenses https://stock.noler.com/us/stock/rain-oncology-inc/operating-income https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-assets https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-cost https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-liability https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-liability-current https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-payments https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-payments-due https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/rain-oncology-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/rain-oncology-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/rain-oncology-inc/other-assets https://stock.noler.com/us/stock/rain-oncology-inc/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/rain-oncology-inc/other-current-assets https://stock.noler.com/us/stock/rain-oncology-inc/other-income https://stock.noler.com/us/stock/rain-oncology-inc/other-noncurrent-assets https://stock.noler.com/us/stock/rain-oncology-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/rain-oncology-inc/other-nonoperating-income https://stock.noler.com/us/stock/rain-oncology-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/rain-oncology-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/rain-oncology-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/rain-oncology-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/rain-oncology-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/rain-oncology-inc/preferred-shares-facts https://stock.noler.com/us/stock/rain-oncology-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rain-oncology-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/rain-oncology-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/rain-oncology-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/rain-oncology-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/rain-oncology-inc/prepaid-insurance https://stock.noler.com/us/stock/rain-oncology-inc/pretax-income https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/rain-oncology-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/rain-oncology-inc/profit-loss https://stock.noler.com/us/stock/rain-oncology-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/rain-oncology-inc/property-plant-equipment https://stock.noler.com/us/stock/rain-oncology-inc/public-float https://stock.noler.com/us/stock/rain-oncology-inc/research-and-development https://stock.noler.com/us/stock/rain-oncology-inc/research-and-development-in-process https://stock.noler.com/us/stock/rain-oncology-inc/restructuring-charges https://stock.noler.com/us/stock/rain-oncology-inc/restructuring-reserve-current https://stock.noler.com/us/stock/rain-oncology-inc/retained-earnings https://stock.noler.com/us/stock/rain-oncology-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/rain-oncology-inc/severance-costs https://stock.noler.com/us/stock/rain-oncology-inc/shareholders-equity https://stock.noler.com/us/stock/rain-oncology-inc/shares-authorized https://stock.noler.com/us/stock/rain-oncology-inc/shares-issued https://stock.noler.com/us/stock/rain-oncology-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/rain-oncology-inc/short-term-investments https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-maximum-employee-subscription-rate https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/rain-oncology-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/rain-oncology-inc/stock-based-compensation https://stock.noler.com/us/stock/rain-oncology-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/rain-oncology-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/rain-oncology-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/rain-oncology-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/rain-oncology-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/rain-oncology-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/rain-oncology-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/rain-oncology-inc/tangible-asset-impairment-charges https://stock.noler.com/us/stock/rain-oncology-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rain-oncology-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/rain-oncology-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/rain-oncology-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/rain-oncology-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/rain-oncology-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/rain-oncology-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/rain-oncology-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/rain-oncology-inc/total-assets https://stock.noler.com/us/stock/rain-oncology-inc/total-liabilities https://stock.noler.com/us/stock/rain-oncology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/rain-oncology-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/rain-oncology-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/rain-oncology-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/rain-oncology-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/rain-oncology-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/rain-oncology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted